N/A
N=554
COVID-19 Treatment Cascade Optimization Study
COVID-19
Bottom Line
View on ClinicalTrials.gov: NCT05305443 ↗Enrolled (actual)
554
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Completion of COVID-19 Test — 72; 60 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Navigation Services (Behavioral); Brief Counseling (Behavioral); Critical Dialogue (Behavioral); Referral and Digital Brochure (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Illinois at Urbana-Champaign
- Primary completion
- Aug 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Completion of COVID-19 Test |
72; 60 | — |
| PRIMARY Stage 2: Reported COVID Test in Last 30 Days at 6 Months Post Baseline |
39; 4; 23; 27; 3; 26 | — |
Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the Comprehensive Behavioral Health Center (CCHC).
Eligibility Criteria
Inclusion Criteria
- over 18 years of age
- having high risk to contract COVID or develop related complications
- able to speak English
- able and willing to provide informed consent.
Exclusion Criteria
- under 18 years of age
- not at high risk to contract COVID or develop related complications
- unable to speak English
- unable and unwilling to provide informed consent
Data sourced from ClinicalTrials.gov (NCT05305443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.